Cervical cancer is cancer that’s found anywhere in the cervix. The cervix is the opening between the vagina and the womb (uterus). It’s part of the reproductive system and is sometimes called the neck of the womb.
All women are at risk for cervical cancer. It occurs most often in women over age 30. Long-lasting infection with certain types of human papillomavirus (HPV) is the main cause of cervical cancer. HPV is a common virus that is passed from one person to another during sex.
The Following are cervical cancer’s most common symptoms:
· vaginal bleeding between periods.
· menstrual bleeding that is longer or heavier than usual.
· pain during intercourse.
· bleeding after intercourse.
· pelvic pain.
· a change in your vaginal discharge such as more discharge or it may have a strong or unusual color or smell.
· vaginal bleeding after menopause.
Treatment depends on the disease stage. For early and non-bulky diseases (less than 4cm), the most common treatment is surgery. Recently, non-surgical operations powered by laser treatment are seizing the place of traditional surgeries being bloodless, safer and faster with remarkable final results.
More specifically, laser surgery, sometimes called laser ablation, is a treatment that may be used to address cervical cancer. Most often performed for women with early stages of cervical cancer, laser surgery involves using a focused laser beam to create heat and burn the cancerous cells.
To perfectly accomplish this sensitive excision task, a proper and highly professional laser machine is needed.
In this vein, the Portable Surgery Laser System FDA SIFLASER-1.2A presents itself as one of the most recommended devices among surgeons viewing its high efficacy in treating such types of cancer.
This device’s blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm ( the high-level laser radiation needed), the machine performs better and gentler cutting, even at lower power.
As such, its improved cutting performance makes it ideally suited to all surgical applications, particularly for cervical cancer.
What also makes the SIFLASER-1.2A highly recommended by surgeons is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam.
To further improve the treatment, the device is supported with a fibre guide laser. So, it is compatible with various endoscopic uses. Also, these special fibres are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.
With a 980 nm wavelength and 15W as maximum power, the device is thought to perfectly address cervical cancer issues.
That is highly attributed to the fact that The SIFLASER-1.2 A uses infrared wavelengths and ultra-blue light to ensure high-level performance.
That is also estimated to reduce thermal damage and its peculiar interaction with haemoglobin.
Due to all these features, the SIFLASER-1.2 A guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.
Since their invention, laser use and applications have expanded rapidly as it proved to be a successful addition to cancer surgery.
In this article, we discuss the benefits of laser therapy and precisely the efficacy of SIFLASER-1.2 A as a surgical laser device capable of efficiently treating the ever-growing issue of cervical cancer among women.
Reference: Cervical cancer
Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFSOF is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser system.
The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.